260 related articles for article (PubMed ID: 21703769)
61. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
[TBL] [Abstract][Full Text] [Related]
62. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
63. Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients.
Jena J; Debata NK; Sahoo RK; Subudhi E
Burns; 2015 Dec; 41(8):1758-1763. PubMed ID: 26188888
[TBL] [Abstract][Full Text] [Related]
64. Resistance to antibiotics in clinical isolates of Pseudomonas aeruginosa.
Sevillano E; Valderrey C; Canduela MJ; Umaran A; Calvo F; Gallego L
Pathol Biol (Paris); 2006; 54(8-9):493-7. PubMed ID: 17027190
[TBL] [Abstract][Full Text] [Related]
65. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
66. [E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].
Triantafilo V; Fica A; Silva M; Thompson L
Rev Med Chil; 1997 Feb; 125(2):149-60. PubMed ID: 9430934
[TBL] [Abstract][Full Text] [Related]
67. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
[TBL] [Abstract][Full Text] [Related]
68. Characterization by phenotypic and genotypic methods of metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Li Y; Zhang X; Wang C; Hu Y; Niu X; Pei D; He Z; Bi Y
Mol Med Rep; 2015 Jan; 11(1):494-8. PubMed ID: 25323940
[TBL] [Abstract][Full Text] [Related]
69. CTX-M-15 and OXA-10 beta lactamases in multi drug resistant Pseudomonas aeruginosa: First report from Pakistan.
Ullah W; Qasim M; Rahman H; Khan S; Rehman ZU; Ali N; Muhammad N
Microb Pathog; 2017 Apr; 105():240-244. PubMed ID: 28258003
[TBL] [Abstract][Full Text] [Related]
70. Antimicrobial resistance pattern, genetic distribution of ESBL genes, biofilm-forming potential, and virulence potential of
Shahbazzadeh M; Moazamian E; Rafati A; Fardin M
Pan Afr Med J; 2020; 36():233. PubMed ID: 33708324
[TBL] [Abstract][Full Text] [Related]
71. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit.
Ozer B; Duran N; Onlen Y; Savas L
J Antibiot (Tokyo); 2012 Jan; 65(1):9-13. PubMed ID: 22086166
[TBL] [Abstract][Full Text] [Related]
72. A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
Navaneeth BV; Sridaran D; Sahay D; Belwadi MR
Indian J Med Res; 2002 Dec; 116():264-7. PubMed ID: 12807154
[TBL] [Abstract][Full Text] [Related]
73. Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia.
Al-Agamy MH; Shibl AM; Tawfik AF; Elkhizzi NA; Livermore DM
J Chemother; 2012 Apr; 24(2):97-100. PubMed ID: 22546765
[TBL] [Abstract][Full Text] [Related]
74. Antibiotic Susceptibility Patterns of Extended Spectrum beta-lactamase and non Extended Spectrum beta-lactamase Pseudomonas aeruginosa Clinical Isolates.
Akbariqomi M; Ghafourian S; Taherikalani M; Mohammadi S; Pakzad I; Sadeghifard N
Recent Pat Antiinfect Drug Discov; 2015; 10(2):128-33. PubMed ID: 26324233
[TBL] [Abstract][Full Text] [Related]
75. Drug resistance profile and molecular characterization of extended spectrum beta-lactamase (ESβL)-producing Pseudomonas aeruginosa isolated from burn wound infections. Essential oils and their potential for utilization.
El-Shouny WA; Ali SS; Sun J; Samy SM; Ali A
Microb Pathog; 2018 Mar; 116():301-312. PubMed ID: 29407236
[TBL] [Abstract][Full Text] [Related]
76. [Investigation of acquired drug-resistant genes and strains relationship in
Fan YF; Cui SY; Zhang C; Xu XM
Zhonghua Shao Shang Za Zhi; 2018 Feb; 34(2):83-87. PubMed ID: 29973025
[No Abstract] [Full Text] [Related]
77. Detection of Pseudomonas aeruginosa isolates carrying the bla
Liu CP; Chen TL; Wang NY; Chow SF; Lin JC; Yan TR
J Microbiol Immunol Infect; 2017 Feb; 50(1):68-74. PubMed ID: 25648667
[TBL] [Abstract][Full Text] [Related]
78. Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.
Betriu C; Gómez M; López-Fabal F; Culebras E; Rodríguez-Avial I; Picazo JJ
Eur J Clin Microbiol Infect Dis; 2010 Sep; 29(9):1179-81. PubMed ID: 20521156
[TBL] [Abstract][Full Text] [Related]
79. Efficacy of methanolic extract of green and black teas against extended-spectrum β-Lactamase-producing Pseudomonas aeruginosa.
Taherpour A; Hashemi A; Erfanimanesh S; Taki E
Pak J Pharm Sci; 2016 Jul; 29(4):1257-61. PubMed ID: 27393439
[TBL] [Abstract][Full Text] [Related]
80. [Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
Sacha PT; Jakoniuk P; Wieczorek P; Zalewska M; Leszczyńska K
Med Dosw Mikrobiol; 2004; 56(3):263-73. PubMed ID: 15773503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
